More Vaccines, Fewer Tests: Why COVID-19 Testing Remains Important
The COVID-19 Response Program for Patients features information tailored to the special needs of patients living with pediatric liver disease, rare liver disease, NASH, pre/post liver transplant and liver cancer.
As COVID-19 vaccination programs are expanding in scale across the United States, it is easy to neglect the fact that effective containment of the pandemic requires not only mass vaccination to establish herd immunity, but also timely testing to prevent the virus from being transmitted from person to person unchecked. However, the number of COVID-19 tests being conducted in the United States is plummeting at an alarming rate, towards which medical professionals and public health experts are expressing concern. In this update, we will walk you through why fewer Americans are getting tested, the importance of expanding the scale of testing despite mass vaccination, and how you can stay vigilant about getting tested when necessary, per the guidance below.
Click here to view the full article.
We Need You in The Fight Against Liver Cancer, Join #OctoberIs4Livers 2021
October 13th 2021The GLI LIVE episode with Dr. Sharpless is the first #OctoberIs4Livers activity in a series of engaging and informative global activities taking place throughout the month of October to raise awareness about liver cancer and address the many disparities that exist with this disease.
Read More
The Need to Support the Restart of Liver Disease Medical Research and Public Health Programs
May 16th 2021Few liver health advocacy organizations have policy staff or personnel in Washington, DC. To fill this gap, we provide liver health policy updates to report on timely information and actionable updates on activities relevant to liver health, including liver cancer, viral hepatitis, autoimmune liver conditions as well as issues that span conditions, such as coverage or other policy decisions.
Read More
